Chapter 63: Reaching an Agreement

The VIP passage at Capital International Airport has been unusually busy these past few days.

Planes from abroad landed one after another.

Genevia Pharmaceutical's Kleisite, Yuansheng Pharmaceutical's Monsabella, Cherry Blossom Biotech's Tanaka Kenji……

Altogether, there were several dozen people.

These titans who command the global pharmaceutical market, now staying at a hotel in the capital, happened to meet in the lobby; after a brief exchange, each returned to their own room.

The person negotiating with them this time was the Minister of Commerce, Cao Fanrong.

The meeting took place in a conference room of the Ministry of Commerce.

On one side of the long conference table sat foreign pharmaceutical representatives with varied expressions; on the other side sat Cao Fanrong's negotiation team, each composed and calm.

Cao Fanrong is about fifty, with an erudite appearance, wearing a pair of glasses.

After the meeting began, he did not waste time on pleasantries; he simply smiled and handed out a report showing the latest domestic cancer patient recovery data to each person.

"Welcome, everyone, and thank you for coming so far. You can first look at some of the latest developments in our nation's Sentinel Therapy."

The conference room was filled only with the sound of pages turning.

As Kleisite and the others read on, their hearts grew heavier.

The plummeting tumor marker data, the before-and-after CT scan comparisons—each hit them like a heavy hammer.

"Minister Cao, we have come this time with the utmost sincerity, hoping to conduct in-depth negotiations with your country on the introduction of Sentinel Therapy."

In the end, it was the hot-tempered Kleisite who spoke first, striving to keep his voice steady.

"Yes, Minister Cao."

Monsabella immediately followed, her Mandarin precise and clear: "Yuansheng Pharmaceutical hopes to obtain the exclusive agency rights for Sentinel in the O State region, and we are willing to pay any reasonable price for it."

The others quickly echoed her sentiment.

For a moment, the conference room rang with words like cooperation, win-win, and benefiting humanity—sounding utterly sincere.

Cao Fanrong listened patiently, fingers interlaced on the table, his calm smile unchanged.

"Thank you for recognizing our technology. However, I must regretfully inform you that we currently have no plan to sell Sentinel Therapy overseas."

That sentence silenced the conference room instantly.

Kleisite frowned, puzzled, and asked:

"Why? Are you intending to keep this life-saving technology solely within Yanhuang Guo? That goes against humanitarian spirit!"

Cao Fanrong's smile remained unchanged, but his tone left no room for doubt:

"Mr. Kleisite, please watch your words. Precisely because we uphold humanitarian principles, we have made this decision."

He glanced at his aide behind him, who immediately projected another document onto the big screen.

"According to our latest national epidemiological statistics, our country has over thirty million cancer patients, with several million new cases each year."

"Moreover, the production process for Sentinel nanorobots is extremely complex, and the production line is currently in a capacity ramp‑up phase."

Cao Fanrong's gaze swept over each person,

"You are all industry experts; you should understand what this means. Even if we ran our existing capacity nonstop, it would meet only the most basic domestic demand."

"In this situation, should we first save our own compatriots, or sell this life‑saving drug to you for huge profit?"

His words were logical, evidence‑based, and seized the moral high ground, leaving the just‑indignant Kleisite suddenly speechless,

his face flushed red, yet he could not utter a single rebuttal.

Monsabella reacted much faster, instantly shifting her approach:

"Minister Cao, we fully understand and respect your decision. We are not asking you to provide the finished product now; we can wait."

"Yuansheng Pharmaceutical is willing to prepay two billion euros as a down payment for technology licensing and future capacity, solely to obtain the agency rights in O State."

"Two billion euros?"

Kleisite snorted, then added, "Genevia Pharmaceutical offers four billion dollars! Exclusive agency rights for North America!"

"Cherry Blossom Biotech is willing to transfer three of its latest biopharmaceutical patents and bid three billion dollars for the agency rights in East Asia!"

Tanaka Kenji also hurriedly threw in his own offer.

The conference room instantly turned into an auction house; these usually proud titans waved cash without hesitation, fearful of falling behind.

Cao Fanrong remained silent throughout, merely watching them calmly.

His team members behind him kept straight faces, but inside they were already bursting with joy.

Such a scene is truly a once‑in‑a‑century occurrence.

When the bidding clamor gradually subsided and everyone looked at him expectantly, Cao Fanrong finally showed a troubled expression,

he even took off his glasses and pressed his fingers to his forehead.

"Your sincerity… I feel it. To be frank, this puts me in a difficult spot."

He slowly put his glasses back on and sighed:

"The terms you offered are indeed very generous. However, the capacity issue is objectively real; it cannot be solved instantly by money or patents."

"Expanding production lines, debugging equipment, and training personnel all take time."

Seeing a possible turning point, Kleisite hurriedly asked, "How long? One year? Two years?"

"At the earliest, it would still take one year."

Cao Fanrong gave a number, then added:

"Moreover, that is the best‑case scenario. To achieve this goal we must immediately pour huge funds into building at least five independent international supply production lines—a venture fraught with risk."

"Money is no problem!"

Monsabella immediately said, "As long as you are willing, we can prepay part of the funds as a dedicated fund for building the production lines!"

"Exactly! We can pay up front! everyone chorused in agreement."

Cao Fanrong had been waiting for exactly those words.

He pondered for a long time, as if he had gone through an extremely difficult ideological struggle, and only then did he seem to have made up his mind.

"All right! Since you're all being so sincere, we can't refuse to be accommodating."

He looked at the crowd and said, enunciating each word: "Agency rights, we can talk about them. But we have several conditions, and these are our bottom line."

"Please go ahead!"

Everyone's hearts were in their throats.

"First, the supply time must be after one year. During this year, we will not provide any finished products, and we also won't be responsible for transportation."

"No problem!"

"Second," Cao Fanrong extended two fingers, his tone becoming especially solemn,

"In order to ensure our invested expansion funds are secured, and also to demonstrate your commitment to cooperation."

"Any company wishing to obtain the agency rights must, within one day after signing the agreement, prepay half of the preliminary fees as a deposit. Moreover, this deposit is non-refundable."

"Third, regarding the profit split, we need to take 45% of the sales revenue, and this is non-negotiable."

"You only get the goods after a year, yet you have to pay half the money up front, and it's not refundable?"

Moreover, a 45% cut is already quite high.

Under normal circumstances, these conditions would be sheer fantasy; they'd laugh at them as a joke.

But after careful consideration, given their company's research progress, not only one year, even five years would be impossible to develop a similar drug.

The conference room first fell silent, then a unanimous response rang out.

"We agree!"

"We completely agree!"

"No problem, Director Cao! When can we sign the agreement?"

Watching this group's anxious, fearful-of-backtracking demeanor, Cao Fanrong's lips finally curled into a barely perceptible arc.